Author:
Koller G.,Katz S.,Charrois T. L.,Ye C.
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Reference23 articles.
1. Seror R, Dougados M, Gossec L (2009) Glucocorticoid sparing effect of tumour necrosis factor alpha inhibitors in rheumatoid arthritis in real life practice. Clin Exp Rheumatol 27:807–813
2. Fortunet C, Pers YM, Lambert J, Godfrin-Valnet M, Constant E, Devilliers H, Gaudin P, Jorgensen C, Prades BP, Wendling D, Maillefert JF (2014) Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice. Rheumatol (United Kingdom) 54:672–677.
https://doi.org/10.1093/rheumatology/keu339
3. Alten R, Nüßlein H, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Pavelka K, Chartier M, Poncet C, Rauch C, Elbez Y, le Bars M (2016) Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study. RMD Open 2:e000228.
https://doi.org/10.1136/rmdopen-2015-000228
4. Weinstein RS (2011) Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 365:62–70.
https://doi.org/10.1056/NEJMcp1012926
5. LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, DellaRocca C (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39–51
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献